These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 29614993)

  • 1. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
    BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapy.
    Kiwata JL; Dorff TB; Todd Schroeder E; Salem GJ; Lane CJ; Rice JC; Gross ME; Dieli-Conwright CM
    BMJ Open; 2017 Jul; 7(7):e016910. PubMed ID: 28698349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial.
    Dawson JK; Dorff TB; Tuzon C; Rice JC; Schroeder ET; Lane CJ; Gross ME; Dieli-Conwright CM
    Integr Cancer Ther; 2021; 20():15347354211035442. PubMed ID: 34301165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.
    Nilsen TS; Raastad T; Skovlund E; Courneya KS; Langberg CW; Lilleby W; Fosså SD; Thorsen L
    Acta Oncol; 2015 Nov; 54(10):1805-13. PubMed ID: 25927504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis.
    Yang U; Harikrishna A; Preda V; Chen J
    Clin Nutr ESPEN; 2023 Dec; 58():27-49. PubMed ID: 38057016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderators of resistance-based exercise programs' effect on sarcopenia-related measures in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
    Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Galvão DA; Buffart LM
    J Geriatr Oncol; 2023 Jun; 14(5):101535. PubMed ID: 37229882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
    BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
    Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
    Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
    Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
    Elife; 2024 Apr; 13():. PubMed ID: 38656229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Leslie WD; Lau YK
    BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.
    Uth J; Schmidt JF; Christensen JF; Hornstrup T; Andersen LJ; Hansen PR; Christensen KB; Andersen LL; Helge EW; Brasso K; Rørth M; Krustrup P; Midtgaard J
    BMC Cancer; 2013 Dec; 13():595. PubMed ID: 24330570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy.
    Newton RU; Jeffery E; Galvão DA; Peddle-McIntyre CJ; Spry N; Joseph D; Denham JW; Taaffe DR
    BJU Int; 2018 Dec; 122(6):986-993. PubMed ID: 29750398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance Exercise Training Increases Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy.
    Houben LHP; Overkamp M; VAN Kraaij P; Trommelen J; VAN Roermund JGH; DE Vries P; DE Laet K; VAN DER Meer S; Mikkelsen UR; Verdijk LB; VAN Loon LJC; Beijer S; Beelen M
    Med Sci Sports Exerc; 2023 Apr; 55(4):614-624. PubMed ID: 36534950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
    Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
    Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review.
    Gardner JR; Livingston PM; Fraser SF
    J Clin Oncol; 2014 Feb; 32(4):335-46. PubMed ID: 24344218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial.
    Fairman CM; Kendall KL; Newton RU; Hart NH; Taaffe DR; Chee R; Tang CI; Galvão DA
    BMJ Open; 2019 Sep; 9(9):e030080. PubMed ID: 31542747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Owen PJ; Daly RM; Dalla Via J; Mundell NL; Livingston PM; Rantalainen T; Fraser SF
    Calcif Tissue Int; 2019 Oct; 105(4):403-411. PubMed ID: 31317232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.